Bray Capital Advisors Bristol Myers Squibb CO Call Options Transaction History
Bray Capital Advisors
- $381 Million
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding BMY
# of Institutions
2,469Shares Held
1.49BCall Options Held
26MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$9.13 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$7.97 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$4.49 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$4.36 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$3.44 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $104B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...